ChemicalBook > Product Catalog >Biochemical Engineering >Inhibitors >Transmembrane Transporters >CFTR modulator >Lumacaftor (VX-809)

Lumacaftor (VX-809)

Lumacaftor (VX-809) Structure
CAS No.
936727-05-8
Chemical Name:
Lumacaftor (VX-809)
Synonyms
Lumacaftor;VX-809;Lumacaftor(vx-809,vx809);3-[6-[[[1-(2,2-Difluoro-1,3-benzodioxol-5-yl)cyclopropyl]carbonyl]amino]-3-methyl-2-pyridinyl]benzoic acid;3-(6-{[1-(2,2-Difluoro-benzo[1,3]dioxol-5-yl)-cyclopropanecarbonyl]-amino}-3-methyl-pyridin-2-yl)-benzoicacid;CS-719;Rumakato;VRT 826809;3-(6-{[1-(2;VX809;VX-809
CBNumber:
CB32489655
Molecular Formula:
C24H18F2N2O5
Molecular Weight:
452.41
MOL File:
936727-05-8.mol
MSDS File:
SDS
Modify Date:
2025/2/21 21:32:25

Lumacaftor (VX-809) Properties

Melting point 200-205oC
Boiling point 653.0±55.0 °C(Predicted)
Density 1.51
storage temp. -20°C Freezer
solubility DMSO (Slightly), Methanol (Slightly)
pka 3.95±0.10(Predicted)
form Solid
color White to Off-White
InChIKey UFSKUSARDNFIRC-UHFFFAOYSA-N
SMILES C(O)(=O)C1=CC=CC(C2=NC(NC(C3(C4=CC=C5OC(F)(F)OC5=C4)CC3)=O)=CC=C2C)=C1

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS07
Signal word  Warning
Hazard statements  H302-H315-H319-H335
Precautionary statements  P261-P305+P351+P338
NFPA 704
0
3 0

Lumacaftor (VX-809) Chemical Properties,Uses,Production

Uses

VX 809 is used in the stabilization of the CFTR protein used in the treatment of cystic fibrosis.

Definition

ChEBI: An aromatic amide obtained by formal condensation of the carboxy group of 1-(2,2-difluoro-1,3-benzodioxol-5-yl)cyclopropane-1-carboxylic acid with the aromatic amino group of 3-(6-amino-3-methylpyridin-2-yl)benzoic acid. Used for the treatment of cystic fi rosis.

Mode of action

CF is a hereditary condition caused by mutations in the CFTR gene, which provides instructions for producing an ion channel protein called CF transmembrane conductance regulator (CFTR). These mutations cause defects in the CFTR protein, which disrupts the normal salt-water transport across the cell membrane and produces thick, sticky mucus that may accumulate in different organs, including the lungs. One of the common mutations in the CFTR gene is the so-called F508del mutation, which results in a defective misfolded CFTR protein. The misfolded protein is degraded by the cell before it can reach the cell membrane. Even if some of the defective proteins reach the cell membrane, they are unable to open correctly and allow the passage of chloride ions. Lumacaftor and ivacaftor work together to restore the function of the CFTR protein at the cell membrane. Lumacaftor increases the stability of defective CFTR proteins, helping them reach the cell membrane and stay there longer. But because it does not address the problem with the opening of the channel, lumacaftor is generally used in combination with ivacaftor, which acts on the defective proteins, helping them to open more often so that the salt-water balance across the cell surface is restored.

Lumacaftor (VX-809) Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 243)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
Ralington Pharma +91-7948911722 +91-9687771722 Gujarat, India 1350 58 Inquiry
Maithri Drugs Pvt Ltd +91-9059204566 +91-9848881740 Telangana, India 64 58 Inquiry
MAITHRI DRUGS PRIVATE LTD +91 40 30438600 New Delhi, India 29 58 Inquiry
CLEARSYNTH LABS LTD. +91-22-45045900 Hyderabad, India 6257 58 Inquiry
A.J Chemicals 91-9810153283 New Delhi, India 6100 58 Inquiry
Pharmaffiliates Analytics and Synthetics P. Ltd +91-172-5066494 Haryana, India 6739 58 Inquiry
Shijiazhuang Dingmin Pharmaceutical Sciences Co., Ltd. +86-0311-67591193 +8613931880626 China 256 58 Inquiry
Hebei Chuanghai Biotechnology Co., Ltd +86-15531157085 +86-15531157085 China 8809 58 Inquiry
Hebei Mujin Biotechnology Co.,Ltd +86 13288715578 +8613288715578 China 12817 58 Inquiry
Zhengzhou Anbu Chem Co.,Ltd +86-0371-88006763; +8615988602810 China 2998 58 Inquiry

Lumacaftor (VX-809) Spectrum

3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxaMido)-3-Methylpyridin-2-yl)benzoic acid VRT 826809 3-(6-{[1-(2,2-Difluorobenzo[1,3]dioxol-5-yl)cyclopropanecarbonyl]-amino}-3-methyl-pyridin-2-yl)be VX 809, >=98% VX-809 (LUMACAFTOR);VX 809 3-[6-[[1-(2,2-difluoro-1,3-benzodioxol-5-yl)cyclopropanecarbonyl]amino]-3-methylpyridin-2-yl]benzoic acid 3-(6-{[1-(2,2-Difluorobenzo[1,3]dioxol-5-yl)cyclopropanecarbonyl]-amino}-3-methyl-pyridin-2-yl VX-809 + IVACAFTOR VX-809 (LuMacaftor) 3-[6-[[[1-(2,2-Difluoro-1,3-benzodioxol-5-yl)cyclopropyl]carbonyl]amino]-3-methyl-2-pyridinyl]benzoic acid VX 809 Lumacaftor VX809;VX-809 3-(6-{[1-(2 Lumacaftor VX809 VX-809, Lumacaftor, VRT 826809 3-{6-[1-(2,2-difluoro-1,3-dioxaindan-5-yl)cycloprop aneamido]-3-methylpyridin-2-yl}benzoic acid 3-(6-{[1-(2,2-Difluoro-benzo[1,3]dioxol-5-yl)-cyclopropaneca... Benzoic acid, 3-[6-[[[1-(2,2-difluoro-1,3-benzodioxol-5-yl)cyclopropyl]carbonyl]amino]-3-methyl-2-pyridinyl]- CS-719 3-(6-{[1-(2,2-Difluoro-benzo[1,3]dioxol-5-yl)-cyclopropanecarbonyl]-amino}-3-methyl-pyridin-2-yl)-benzoicacid VX-809 3-[6-[[[1-(2,2-Difluoro-1,3-benzodioxol-5-yl)cyclopropyl]carbonyl]amino]-3-methyl-2-pyridinyl]benzoic acid Lumacaftor Lumacaftor(vx-809,vx809) 3-(6-(1-(2,2-Difluorobenzod1,3dioxol-5-yl)cyclopropane-carboxcarboxamido)-3-methylpyridin-2-yl)-benzoic acid Lumacaftor in methanol Rumakato Lumacaftor, 10 mM in DMSO 936727-05-8 Inhibitors VX-809